Skip to content
healthcare.dev

Zileuton

NDC 31722-044, Zileuton, tablet, film coated, extended release, from Camber Pharmaceuticals, Inc..

Product NDC
31722-044
Status
Listed
Labeler
Camber Pharmaceuticals, Inc.
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215742
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/31722-044 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ZILEUTON600 mg/1

Pharmacologic classes

5-Lipoxygenase Inhibitor [EPC]; 5-Lipoxygenase Inhibitors [MoA]; Decreased Leukotriene Production [PE]

Package NDCNDC-11Package
31722-044-1231722004412120 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (31722-044-12)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/94313e24-9534-4b6c-b374-c436c4916303
  • NADAC price for package 31722004412

    GET /v1/drugs/nadac/31722004412

Use it

Look up 31722-044 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/31722-044 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 31722-044. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.